Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Diphenylcyclopropenon treatment for Alopecia areata is effective and safe, improving patients' quality of life.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

The new method improves finasteride's effectiveness for hair loss treatment.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Topical tacalcitol ointment can help improve symptoms of EFFC.

Kerion, a scalp fungal infection, requires lab confirmation and is treated with antifungal medication and medicated shampoo.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

The method shows that zinc pyrithione and climbazole from anti-dandruff shampoo effectively reach the scalp.

Upadacitinib effectively treats psoriasis and lichen planus together.

New molecules can prevent cell death in hair follicles.

Vitamin C derivative reduces hair loss-related protein in cells.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

ULBP3 levels are higher in Tinea capitis patients and may help predict the disease's severity.

Cuscuta reflexa extract may help treat hair loss caused by hormones.

The serum with microneedling effectively treats alopecia areata by enhancing drug delivery and is safe and patient-friendly.

The supplement did not work better than a placebo for hair loss in women over 60.

The cosmetic product effectively reduced hair growth and thickness on forearms.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Modulating Cytochrome P450 activity could help develop new skin disease treatments.

Scopolin and scopoletin from Merremia peltata leaves may help treat hair loss and showed promising results in rabbit tests.

A medication for skin rash also unexpectedly treated hair loss in a patient.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

CS-891 may effectively treat hair loss by blocking enzymes in hair follicles.

A 9-year-old girl with a healthy immune system was successfully treated for a severe fungal scalp infection caused by Microsporum audouinii.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Baricitinib helps with early hair regrowth in people with alopecia areata.

A microemulsion with Carthamus tinctorius extract effectively inhibits 5α-reductase and improves skin and hair follicle delivery.